(Insight Human) A new drug offers hope to people suffering from Multiple Sclerosis (MS).In clinical trials, the drug reduced nerve damaged in patients by almost 50%.
Research tested an oral drug called ibudilast in patients with progressive Multiple Sclerosis (MS). 255 Multiple Sclerosis patients were recruited from medical centers and were randomly assigned to take either ibudilast or placebo pills for 96 weeks.
MRI brain scans were performed to track how the disease‚Äôs was affecting the patients. Results showed that patients on the drug had 48% less atrophy in their brain tissue. Ibudilast reduces the nerve damage by slowing brain shrinkage rate. The drug is also well tolerated with only limited side effects. Main side effects observed were gastrointestinal, nausea, diarrhoea and headaches.